Frank X. Leonard - 15 Sep 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Development Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Issuer symbol
NVCR
Transactions as of
15 Sep 2022
Net transactions value
-$1,046,775
Form type
4
Filing time
19 Sep 2022, 16:10:41 UTC
Previous filing
12 Sep 2022
Next filing
26 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $39,447 +5,517 +7.1% $7.15* 82,913 15 Sep 2022 Direct F1
transaction NVCR Ordinary Shares Sale $589,692 -6,754 -8.1% $87.31 76,159 15 Sep 2022 Direct F1
transaction NVCR Ordinary Shares Sale $496,530 -5,517 -7.2% $90.00 70,642 15 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -5,517 -50% $0.000000 5,517 15 Sep 2022 Ordinary Shares 5,517 $7.15 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard.
F2 Fully vested as of the date hereof.